Amgen Inc. AMGN Cash Flow

Amgen inc. (AMGN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent
7,675	7,842	8,067	7,958	8,075	8,394	2,202	2,364	2,219	1,979	8,178	8,174	7,893	7,722	7,587	7,433	7,216	6,939	6,433	5,814	5,708	5,158	4,885	5,009	4,720	5,081	4,848	4,587	4,595	4,345	4,491	3,838	3,742	3,683	3,771	4,553	4,585	4,627	4,536	4,686	4,753	4,605	0	0	0
Depreciation, amortization and other
2,608	2,206	1,994	1,987	1,970	1,946	1,905	1,868	1,902	1,955	2,065	2,104	2,108	2,105	2,088	2,108	2,105	2,108	2,091	2,111	2,098	2,092	2,011	1,756	1,527	1,286	1,115	1,114	1,106	1,088	1,076	1,054	1,046	1,060	1,060	1,048	1,038	1,017	1,013	1,032	1,034	1,049	0	0	0
Share-based Payment Arrangement, Noncash Expense
-	-	-	-	-	-	-	-	-	329	333	328	319	311	302	301	304	322	348	369	391	408	401	398	398	403	395	386	379	362	367	347	339	341	350	361	362	353	323	327	293	284	0	0	0
Deferred income taxes
-323	-289	-241	-319	-341	-363	-1,245	-1,264	-1,325	-1,330	-276	-242	174	183	938	978	584	607	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other items, net
-269	-186	853	535	460	386	79	262	251	334	-320	-99	88	-32	79	109	-32	146	-342	-168	-21	-56	134	43	-229	-199	-71	-200	179	74	40	40	-116	-63	-52	-32	-164	-140	0	0	0	-	-	-	-
Changes in operating assets and liabilities, net of acquisition:
Trade receivables, net
1,252	504	207	258	201	378	63	15	395	58	251	486	163	214	310	340	509	420	511	63	53	-136	-439	-95	-123	38	-18	-28	-459	-348	-27	1	468	557	279	480	229	210	95	27	262	36	0	0	0
Inventories
151	66	11	-14	-76	3	-94	-88	-151	-133	9	14	72	80	-72	-129	-297	-481	-512	-483	-381	-327	-163	-67	-2	7	46	116	146	150	285	257	321	383	284	161	-54	-153	-90	64	135	134	0	0	0
Other assets
-578	-10	124	-109	79	-35	24	62	4	24	-97	-8	34	128	372	260	-45	-155	-311	-95	-41	1	5	158	230	59	263	211	-247	-124	-252	-168	275	204	133	-200	-1	-20	60	84	-77	3	0	0	0
Accounts payable
251	164	-28	-19	23	-143	163	138	166	424	53	13	86	-44	-85	86	55	-12	50	-95	-81	228	158	68	117	60	-22	90	-30	161	99	-28	27	-95	-48	115	-62	142	213	171	335	71	0	0	0
Accrued income taxes, net
-725	-585	-105	-304	-437	-361	91	329	608	523	-113	-93	-27	-301	-109	-188	418	509	699	397	30	-103	-167	135	32	-326	-311	-448	-259	87	224	-102	-88	-20	-183	-334	-459	-656	-977	-360	-507	-142	0	0	0
Long-term tax liabilities
-172	-146	-208	-198	295	258	6,571	6,629	6,620	6,681	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
745	396	463	208	410	1,214	746	641	891	231	109	-49	59	323	100	224	422	-7	880	1,412	909	759	368	0	-110	116	-9	128	361	165	-15	463	485	773	1,270	575	503	234	297	344	503	353	0	0	0
Net Cash Provided by (Used in) Operating Activities
9,439	9,150	9,830	9,726	10,414	11,296	11,114	11,295	11,519	11,177	11,265	10,473	10,824	10,354	9,327	9,557	10,164	9,731	10,500	10,349	9,292	8,952	8,180	7,246	6,619	6,526	5,268	5,184	5,959	5,882	6,654	5,900	5,061	5,119	5,543	5,876	5,904	5,787	5,602	6,275	6,390	6,336	0	0	0
Cash flows from investing activities:
Purchases of marketable securities
2,625	9,394	15,186	19,258	22,907	18,741	19,563	21,096	29,262	33,607	32,073	32,369	26,576	28,094	28,867	27,416	27,641	25,977	24,839	23,815	29,925	25,878	24,918	26,784	17,885	21,965	25,255	24,780	27,072	26,241	21,566	20,211	20,113	21,183	21,463	20,202	18,645	14,602	13,149	12,542	11,998	12,418	0	0	0
Proceeds from sales of marketable securities
11,291	8,842	3,316	4,850	11,787	28,356	33,719	33,538	35,322	24,240	22,466	23,320	19,672	17,958	20,317	19,071	16,928	18,029	17,421	15,581	19,885	16,697	14,440	17,292	14,921	19,123	20,571	19,222	18,645	17,372	15,042	15,970	18,678	20,871	20,857	19,258	15,248	10,485	9,227	8,133	6,996	8,252	0	0	0
Proceeds from maturities of marketable securities
10,206	20,548	19,972	18,036	14,967	5,412	5,290	3,883	5,546	6,174	5,292	4,404	3,529	2,459	2,280	2,366	2,784	3,527	3,416	3,404	4,443	4,199	4,206	4,444	3,123	5,090	5,962	5,518	4,758	1,994	1,052	758	685	749	787	760	725	642	533	769	1,159	1,443	0	0	0
Purchases of property, plant and equipment
644	618	655	656	699	738	666	653	651	664	738	747	750	738	716	687	632	594	592	624	664	718	716	721	707	693	692	690	703	689	713	660	611	567	525	532	586	580	542	545	507	530	0	0	0
Purchases of equity method investments
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for acquisitions, net of cash acquired
-	-	-	-	-	-195	-178	-178	-178	19	0	0	0	-	-	-	-	-	-	-	-	165	9,549	9,549	9,538	9,434	400	719	1,421	2,390	1,990	1,671	1,267	701	701	701	403	0	0	0	0	-	-	-	-
Change in restricted investments, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-533	-539	-13	849	520	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
47	52	233	175	153	145	60	60	94	148	115	288	300	243	327	257	339	447	435	230	197	138	116	175	128	90	17	-38	17	11	4	49	-51	-45	12	54	91	97	69	-35	-54	-51	0	0	0
Net cash (used in) provided by investing activities
1,924	5,709	7,035	2,795	2,988	14,339	18,898	15,790	11,039	-4,024	-5,168	-5,581	-4,425	-8,658	-7,669	-7,283	-8,985	-5,547	-4,940	-5,840	-5,939	-5,752	-16,244	-15,460	-11,043	-8,469	-382	-1,436	-5,835	-9,990	-8,179	-5,863	-2,577	-786	-1,057	-1,471	-3,752	-4,152	-4,000	-4,150	-4,296	-3,202	0	0	0
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt
0	-	-	-	0	-	-	-	-	-	-	-	-	7,318	6,714	2,909	6,374	3,465	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,471	2,471	989	989	1,980	0	0	0
Repayments of Long-term Debt
6,750	4,500	5,114	4,250	2,100	1,100	495	495	3,795	4,400	5,380	7,105	4,180	3,700	2,850	1,250	2,400	2,400	4,400	4,400	5,605	5,605	4,351	4,226	996	3,371	2,521	2,521	2,539	123	102	102	84	2,500	2,500	2,500	2,500	0	0	0	0	-	-	-	-
Repurchases of common stock
5,631	7,702	8,732	9,300	10,129	17,794	16,459	15,539	13,271	3,160	3,354	3,309	2,875	2,965	2,165	2,145	2,079	1,867	1,822	1,078	602	138	0	0	0	832	2,049	2,859	4,064	4,607	8,688	10,150	9,676	8,315	4,209	2,231	2,213	3,786	3,805	3,511	2,798	3,208	0	0	0
Dividends paid
3,553	3,509	3,489	3,472	3,457	3,507	3,501	3,488	3,469	3,365	3,278	3,187	3,093	2,998	2,847	2,699	2,549	2,396	2,264	2,129	1,990	1,851	1,741	1,631	1,522	1,415	1,335	1,260	1,186	1,118	1,089	1,065	785	500	0	0	0	-	-	-	-	-	-	-	-
Settlement of contingent consideration obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	253	317	317	317	92	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock in connection with the Companys equity award programs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	186	181	183	241	296	427	916	1,007	1,288	1,245	713	600	242	0	0	0	-	-	-	0	-	0	0	0
Other
88	95	76	42	48	58	103	103	80	51	126	139	87	31	-216	-215	-64	81	-86	-78	-61	-25	54	43	-57	-102	-24	-21	48	46	44	25	15	12	-61	-36	9	3	252	238	199	204	0	0	0
Net cash used in financing activities
-11,034	-15,767	-17,406	-17,127	-15,785	-22,490	-21,056	-19,583	-16,175	-6,594	-6,582	-4,893	-5,937	-2,599	-1,399	-3,439	-1,147	-3,771	-6,011	-5,066	-4,176	-3,274	3,460	6,760	5,581	2,491	-2,428	-3,791	-1,801	419	3,457	-186	457	-674	-3,546	-119	-3,152	-1,232	-2,228	-3,381	-2,605	-2,024	0	0	0
(Decrease) increase in cash and cash equivalents
329	-908	-541	-4,606	-2,383	3,145	8,956	7,502	6,383	559	-485	-1	462	-903	259	-1,165	32	413	-451	-557	-823	-74	-4,604	-1,454	1,157	548	2,458	-43	-1,677	-3,689	1,932	-149	2,941	3,659	940	4,286	-1,000	403	-626	-1,256	-511	1,110	0	0	0